Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. 2invest AG
  6. News
  7. All News
    2INV   DE000A3H3L44

2INVEST AG

(2INV)
  Report
Delayed Xetra  -  11:36:17 2023-02-08 am EST
9.140 EUR   +0.22%
2022Theta Gold Mines Limited (asx : TGM) Issue of New Call Options to 2Invest AG
AQ
20222invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022Theta Gold Mines Limited (asx : TGM) Option to Extend Secure Bond Maturity Date
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about 2INVEST AG
2022Theta Gold Mines Limited (asx : TGM) Issue of New Call Options to 2Invest AG
AQ
20222invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022Theta Gold Mines Limited (asx : TGM) Option to Extend Secure Bond Maturity Date
AQ
20222invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2022Heqet Therapeutics S.R.L. announced that it has received ú6.6 million in funding from C..
CI
2022Kither Biotech s.r.l. announced that it has received €18.5 million in funding from..
CI
20222invest : Preliminary annual results as of 31 December 2021
PU
20212invest : Change of forecast for the financial year 2021
PU
2021Revocation of the admission to the Prime Standard
PU
2021Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Ca..
CI
20212Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
20212invest : Preliminary half-year results as of 30.06.2021
PU
20212invest : Report of the Supervisory Board of 2invest AG for the financial year from 1 Janu..
PU
20214basebio : Quarterly statement as at 31 March 2021 published
PU
20214basebio : Application for change from Prime Standard to General Standard
PU
20214BASEBIO AG : REVERSE SPLIT: 1 of 9
FA
20214basebio : Implementation of the reverse stock split of 4basebio AG
PU
20214basebio : KROMI takeover offer will not be pursued further
PU
20214basebio : Preliminary annual result as of 31.12.2020
PU
20214Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2020
CI
20214BASEBIO AG : Spin off
FA
20214basebio : Further processing of the spin-off
PU
20214basebio : reports on results of the Extraordinary General Meeting 2021
PU
20214basebio : Decision to make a public takeover offer to the shareholders of KROMI Logistik ..
PU
20214basebio AG cancelled the acquisition of KROMI Logistik AG.
CI
20204basebio AG Announces Board Changes
CI
20204basebio : Update regarding the status of the settlement of the spin-off
PU
20204basebio : reports on registration of spin-off and explains further settlement process
PU
20204basebio AG completed the spin-off of Genomics and DNA manufacturing business.
CI
20204basebio : reports change in Supervisory Board and new appointment to the Executive Manage..
PU
20204basebio AG Announces Board Changes
CI
20204Basebio Ag Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
20204basebio : reports first nine months of 2020 financial results
PU
2020Expedeon : 4basebio reports on results of Extraordinary General Meeting 2020
PU
2020Expedeon : 4basebio announces share capital reduction by way of reverse stock split
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : 4basebio AG signs term sheet for investment in nanoparticle-based gene therapy ..
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : 4basebio comments on the takeover bid of Sparta AG
PU
20204basebio Ag : 4basebio comments on the takeover bid of Sparta AG
EQ
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
PU
2020Expedeon : 4basebio AG announces process for spin-off and separate stock market listing fo..
PU
20204basebio : announces process for spin-off and separate stock market listing for its DNA bu..
EQ
2020The Board of Directors of 4basebio AG announced the spin-off of unknown majority stake ..
CI
2020Transcript : 4basebio AG, H1 2020 Earnings Call, Aug 13, 2020
CI
20204basebio AG Reaffirms Earnings Guidance for the Full Year of 2020
CI
20204basebio Ag : 4basebio AG reports first six months of 2020 financial results
EQ
20204Basebio Ag Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
20204basebio Ag : 4basebio informs about takeover bid by Sparta AG
EQ
2020Sparta AG (DB:SPT6) made an offer to acquire remaining 95.8% stake in 4bas..
CI
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
2020Expedeon : Managers' transactions announcement according to article 19 MAR
PU
20204basebio Ag : 4basebio reports on results of Annual General Meeting 2020
EQ
20204basebio Ag : Notification and public disclosure of transactions by persons
EQ
20204basebio Ag : Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio's contribu..
EQ
20204basebio Ag : 4basebio AG reports first quarter 2020 financial results
EQ
20204basebio AG Reaffirms Earning Guidance for the Fiscal Year 2020
CI
2020Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019.
CI
2020Transcript : 4basebio AG, 2019 Earnings Call, Apr 24, 2020
CI
20204basebio Ag : 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financ..
EQ
20204Basebio Ag Reports Earnings Results for the Full Year Ended December 31, 2019
CI
2020Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019.
CI
1  2  3  4Next
Upcoming event on 2INVEST AG